DAVENPORT 13F: Adds $102M to Synopsys (SNPS) Stake
Institutional filing reveals Davenport lifted its Synopsys, Inc. position significantly during the period.
Reviewed by automated data checks against the source filing. How we make and check alerts
DAVENPORT added 237,465 shares to its stake in Synopsys, Inc. ($SNPS), a 2362.60% increase, according to a 13F filing with the SEC dated October 14, 2026. It reported 247,516 shares worth $106.63 million at the end of the quarter.
Since the filing, $SNPS is down 5.3% to date (from the $479.93 close on Oct 14, 2026).
Key Points
- Davenport increased its stake in Synopsys, Inc. by 237,465 shares, bringing its total holding to 247,516 shares valued at roughly $106.6 million.
- Synopsys recently traded around $452.03, sitting above both its 50-day and 200-day moving averages as it heads toward its next earnings report on December 9, 2026.
- Major financial institutions like Blackrock Inc. and Vanguard Capital Management also adjusted their positions in the semiconductor software provider during recent reporting periods.
Get $SNPS trade alerts by text
We text you when insiders, Congress or big funds trade $SNPS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Synopsys, Inc. alert may contain errors. Disclosures
Davenport significantly expanded its investment in Synopsys, Inc. (NasdaqGS: SNPS), according to a Form 13F filing with the SEC on October 14, 2026. Because 13F reports look backward at a prior period, this filing reflects holdings as of that reporting window and might not show the investor's current position today.
What Changed in Davenport's Synopsys Position
Davenport boosted its holdings by adding 237,465 shares during the period. That marked a sharp 2,362.6% increase, bringing the firm's total stake to 247,516 shares. The reported value of this position reached about $106.6 million, up from just 10,051 shares previously.
Other Institutional Activity in Synopsys
Other large institutional investors made their own adjustments to Synopsys during recent reporting periods. Blackrock Inc. grew its holdings by 337,946 shares, ending with 16,203,958 shares worth about $7.4 billion. Vanguard Capital Management LLC lifted its stake by 64,700 shares to finish with 12,507,020 shares valued at approximately $5.7 billion. State Street Corporation added 174,429 shares, resulting in a position of 9,073,873 shares worth about $4.1 billion. Invesco Ltd. increased its holdings by 116,473 shares to end with 6,028,804 shares valued at roughly $2.7 billion. Conversely, FMR, LLC cut back its position by 2,375,837 shares, leaving it with 5,989,785 shares worth about $2.7 billion.
Synopsys, Inc. Stock Down 5.8%
Synopsys shares recently traded around $452.03 as of October 16, 2026. The stock sits about 5.9% above its 50-day moving average of $427.03 and roughly 1.3% above its 200-day moving average of $446.01. Shares remain about 16.2% below their 52-week high of $539.48 while holding 24.7% above their 52-week low of $362.55.
Recent Earnings
Synopsys reported trailing-twelve-month revenue of $9.42 billion alongside trailing earnings of $5.66 per share. The company posted a net profit margin of 11.4% and a return on equity of 3.7%, with revenue growing at a 42.4% clip year-over-year. The company's next earnings report is scheduled for December 9, 2026.
Insider Buying and Selling at Synopsys, Inc.
Company insiders also reported transactions ahead of the filing. Officer and Director Geus Aart J De disposed of 49,641 shares in a transaction valued at about $21.4 million on September 1, 2026. Chief Executive Officer Sassine E Ghazi sold 14,604 shares at an average price of $374.88 for a total value of about $5.5 million on September 15, 2026. Officer Sudhindra Kankanwadi parted with 12,170 shares worth about $6.0 million on October 6, 2026. General Counsel Janet Lee sold 1,143 shares valued at about $574,685 on the same day.
Analysts Set New Price Targets
Wall Street firms have actively updated their views on the stock. On September 25, 2026, HSBC upgraded the stock to a Buy rating and raised its target to $700.00 from $490.00. Wells Fargo maintained an Overweight rating on October 1, 2026, lifting its target from $475.00 to $540.00. Keybanc maintained an Overweight rating on the same day, moving its target from $600.00 to $605.00. Rosenblatt reiterated a Buy rating and raised its target from $575.00 to $620.00 on October 1, 2026. Needham also maintained a Buy rating on October 12, 2026, taking its target from $580.00 to $620.00. Across the broader analyst community, Synopsys holds a consensus Strong Buy recommendation with a mean price target of $583.99 from 25 covering opinions.
About Synopsys
Synopsys, Inc. provides design IP solutions and software tools for the semiconductor and electronics industries. Operating across Design Automation and Design IP segments, the company helps engineers build advanced microchips. Institutional interest from firms like Davenport underscores the ongoing capital allocation toward key infrastructure providers powering modern electronics.
Bottom Line
Investors tracking Davenport will want to watch future SEC filings to see if this large position expansion is maintained. Synopsys's next earnings release on December 9, 2026, will offer fresh insight into the company's financial performance. Remember that 13F filings are historical snapshots and may not reflect current portfolio weightings. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.
Source: DAVENPORT's 13F filing on $SNPS (Oct 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: DAVENPORT 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
